Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss
- Posted on March 23, 2026
- By CNBC
- 7 Views
Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss
Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.
